Protara Therapeutics, Inc.

NasdaqGM:TARA Stock Report

Market Cap: US$34.3m

Protara Therapeutics Management

Management criteria checks 3/4

Protara Therapeutics' CEO is Jesse Shefferman, appointed in Nov 2017, has a tenure of 6.42 years. total yearly compensation is $2.78M, comprised of 21.1% salary and 78.9% bonuses, including company stock and options. directly owns 7.32% of the company’s shares, worth $2.51M. The average tenure of the management team and the board of directors is 2.3 years and 4.3 years respectively.

Key information

Jesse Shefferman

Chief executive officer

US$2.8m

Total compensation

CEO salary percentage21.1%
CEO tenure6.4yrs
CEO ownership7.3%
Management average tenure2.3yrs
Board average tenure4.3yrs

Recent management updates

Recent updates

Protara: A Bombed Out Biotech With A Very Positive Skew

Feb 22

Here's Why We're Watching Protara Therapeutics' (NASDAQ:TARA) Cash Burn Situation

Dec 16
Here's Why We're Watching Protara Therapeutics' (NASDAQ:TARA) Cash Burn Situation

We Think Protara Therapeutics (NASDAQ:TARA) Can Afford To Drive Business Growth

Apr 22
We Think Protara Therapeutics (NASDAQ:TARA) Can Afford To Drive Business Growth

The Prognosis For Protara Therapeutics

Oct 13

Here's Why We're Not Too Worried About Protara Therapeutics' (NASDAQ:TARA) Cash Burn Situation

Sep 12
Here's Why We're Not Too Worried About Protara Therapeutics' (NASDAQ:TARA) Cash Burn Situation

Will Protara Therapeutics (NASDAQ:TARA) Spend Its Cash Wisely?

Mar 21
Will Protara Therapeutics (NASDAQ:TARA) Spend Its Cash Wisely?

Is Protara Therapeutics (NASDAQ:TARA) In A Good Position To Deliver On Growth Plans?

Dec 06
Is Protara Therapeutics (NASDAQ:TARA) In A Good Position To Deliver On Growth Plans?

Will Protara Therapeutics (NASDAQ:TARA) Spend Its Cash Wisely?

Aug 17
Will Protara Therapeutics (NASDAQ:TARA) Spend Its Cash Wisely?

CEO Compensation Analysis

How has Jesse Shefferman's remuneration changed compared to Protara Therapeutics's earnings?
DateTotal CompensationSalaryCompany Earnings
Dec 31 2023n/an/a

-US$40m

Sep 30 2023n/an/a

-US$69m

Jun 30 2023n/an/a

-US$67m

Mar 31 2023n/an/a

-US$64m

Dec 31 2022US$3mUS$588k

-US$66m

Sep 30 2022n/an/a

-US$37m

Jun 30 2022n/an/a

-US$40m

Mar 31 2022n/an/a

-US$45m

Dec 31 2021US$4mUS$570k

-US$47m

Sep 30 2021n/an/a

-US$46m

Jun 30 2021n/an/a

-US$43m

Mar 31 2021n/an/a

-US$37m

Dec 31 2020US$8mUS$507k

-US$34m

Sep 30 2020n/an/a

-US$28m

Jun 30 2020n/an/a

-US$22m

Mar 31 2020n/an/a

-US$16m

Dec 31 2019US$379kUS$344k

-US$8m

Sep 30 2019n/an/a

-US$7m

Dec 31 2018US$301kUS$268k

-US$4m

Compensation vs Market: Jesse's total compensation ($USD2.78M) is above average for companies of similar size in the US market ($USD667.11K).

Compensation vs Earnings: Jesse's compensation has been consistent with company performance over the past year.


CEO

Jesse Shefferman (51 yo)

6.4yrs

Tenure

US$2,780,896

Compensation

Mr. Jesse Shefferman is the Co-Founder of Proteon Therapeutics Inc. (Formerly known as Protara Therapeutics, Inc. (formerly known as ArTara Therapeutics, Inc.).) and served as its Principal Financial Offic...


Leadership Team

NamePositionTenureCompensationOwnership
Jesse Shefferman
Co-Founder6.4yrsUS$2.78m7.32%
$ 2.5m
Jacqueline Zummo
Co-Founder3.3yrsUS$1.30m0.55%
$ 190.0k
Jathin Bandari
Executive Officer2.5yrsUS$1.17m0.12%
$ 40.6k
Patrick Fabbio
Chief Financial Officer1.3yrsno datano data
Hannah Fry
VP, Principal Accounting Officer & Controller1.8yrsno data0.15%
$ 51.1k
Justine O'Malley
Senior Vice President of Investor Relations & Corporate Affairs2.3yrsno datano data
Mary Grendell
General Counsel & Corporate Secretary2.3yrsno datano data

2.3yrs

Average Tenure

42yo

Average Age

Experienced Management: TARA's management team is considered experienced (2.3 years average tenure).


Board Members

NamePositionTenureCompensationOwnership
Jesse Shefferman
Co-Founderno dataUS$2.78m7.32%
$ 2.5m
Luke Beshar
Independent Chairman of the Board5.5yrsUS$197.11k0.26%
$ 90.0k
Richard Levy
Independent Director4.3yrsUS$123.11k0.27%
$ 93.0k
Gregory Sargen
Independent Director4.4yrsUS$80.61k0.27%
$ 93.0k
Michael Solomon
Independent Director4.3yrsUS$77.02k0.23%
$ 79.5k
Roger Garceau
Independent Director5.3yrsUS$96.61k0%
$ 0
Cynthia Smith
Independent Director3.3yrsUS$77.19k0%
$ 0
Barry Flannelly
Independent Director3.8yrsUS$71.61k0%
$ 0
Edna Huang
Independent Director2.8yrsUS$90.61k0%
$ 0

4.3yrs

Average Tenure

57yo

Average Age

Experienced Board: TARA's board of directors are considered experienced (4.3 years average tenure).


Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.